Stockreport

Esperion Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF momentum, announcing a planned acquisition of Corstasis to gain global rights to Enbumyst , an FDA-approved intranasal loop diuretic; the deal is expected to close in Q2 [Read more]